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Two host range switch mutants of the immunosuppressive strain of parvovirus Minute Virus of Mice (MVMi) were isolated from plaques
on A9 fibroblasts. Both carried a single coding mutation at residue D399 in VP2, to alanine and glycine in hr105 and hr107, respectively, and
a second, non-coding, guanine-to-adenine change at nucleotide 1970 in hr105 and 1967 in hr107. These mutations were recreated in a wild
type MVMi infectious plasmid clone, both alone and as pairs, in either the original or switched combinations. All single mutants failed to
replicate productively in fibroblasts, but the two pairs of changes were functionally equivalent. Single D399 mutations allowed the viruses to
initiate infection in fibroblasts, but NS2 expression was severely restricted and correlated with poor accumulation and release of progeny
virus. Mutations at 1967 or 1970 enhanced NS2 accumulation, and allowed efficient progeny production and release. Conversely, the D399
mutations destroyed the viruses’ ability to infect EL4 lymphocytes. In all productive EL4 infections, NS2 was expressed at high ratios even in
the absence of upstream mutations, and progeny accumulation was efficient. However, EL4 cells lack a mechanism for early progeny release,
potentially explaining why virus amplification in these cells is slow.
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Restrictive infectionIntroduction
Minute Virus of Mice (MVM), the type species of the
genus Parvovirus (Tattersall et al., 2005), exhibits subtle
strain-specific variations that allow different isolates to grow
productively in murine cells of dissimilar differentiated
phenotypes. The two independently isolated strains, termed0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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University, 130021 Changchun, People’s Republic of China.allotropic variants, that were initially identified are the
prototype strain (MVMp), which grows productively in
fibroblasts, and the ‘‘immunosuppressive’’ strain (MVMi),
which replicates productively in T lymphocytes and
erythrocyte progenitors (Segovia et al., 1991; Tattersall et
al., 1973). Despite sharing 97% sequence identity and being
serologically indistinguishable, these viruses are recipro-
cally restricted for growth in each other’s host cell type
(Tattersall and Bratton, 1983). The ability of MVMp to
grow in fibroblasts has been mapped to two specific amino
acids at positions 317 and 321 in the VP2 capsid protein
sequence (Ball-Goodrich and Tattersall, 1992; Gardiner and
Tattersall, 1988), which lie at or near the particle surface,
adjacent to a dimple-like depression that spans the
icosahedral 2-fold axis of the virion (Agbandje-McKenna
et al., 1998). Crystallographic studies have recently identi-
fied this depression as the likely site at which MVMp05) 143 – 154
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directly for canine parvovirus (Barbis et al., 1992; Tresnan
et al., 1995).
When a restriction fragment from MVMp differing at
only these two VP2 residues (T317 and G321) was
substituted into an infectious plasmid clone of MVMi
(A317 and D321), the resulting virus was found to be
>100-fold better at infecting fibroblasts than its parent
(Gardiner and Tattersall, 1988). In contrast, when either
single change was introduced into MVMi separately, the
resulting viruses showed at most a 2-fold increase in their
ability to replicate in fibroblasts (Ball-Goodrich and
Tattersall, 1992), which, in turn, allowed the selection
of second site mutants that could complement either of
these changes (Agbandje-McKenna et al., 1998). For each
of the single mutants, multiple alternative second siteFig. 1. Positions and sequences of host range mutations. The DNA sequences of th
surrounding position 399 in VP2 are shown above and below a diagram of the vi
mutants analyzed in this study are shown, with reference to adjacent landmarks, ab
P38 denote the two viral promoters, and the hairpin sequences at each end of the vi
single strand, shown as the negative, packaged sense.mutations were identified, all affecting residues surround-
ing or extending down the sides of the 2-fold related
dimple. Surprisingly, if the MVMi backbone already
carried the A317T mutation, complementing mutations
in D321 were not selected, but instead mutations D399G,
D399A, V551A, or D553N were found to effectively
confer fibrotropism. In contrast, when the MVMi back-
bone already carried the D321G mutation, four of the six
second-site mutants identified carried the MVMp A317T
change, while in the other two, the compensating
mutations were S460A and Y558H. Thus, in an MVMi
backbone, fibrotropism can be conferred by switching the
side chains of a number of different residues that
surround the 2-fold depression, suggesting that structural
changes in this depression may mediate host range.
However, in each reported case, mutations of at leaste MVMi positive strand for the major splice acceptor region and the region
ral coding strategy. Positions and sequence changes found in the host range
ove the predicted protein coding sequences embedded within them. P4 and
ral genome are scaled up approximately 20-fold compared to the intervening
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involved removal of an acidic charge.
Spontaneously occurring host range mutants exist in
MVM stocks at very low frequency but can be selected by
forced passage in cultures of a restrictive host cell type (Ron
et al., 1984; Ball-Goodrich et al., 1991). Forced passage of a
restricted virus can establish a persistent infection, during
which host range variants can arise and destroy the cell
culture. However, in some cell types, continued passage will
lead to the emergence of cell variants that are resistant to the
emerging virus (Ron and Tal, 1985), and such co-evolution
can continue until spontaneous curing occurs due to the
emergence of a host cell variant resistant to all potential
virus variants, usually due to non-expression of the cell
surface virus receptor (Ron and Tal, 1986). In this paper, we
describe two new host range variants of MVMi, hr105 and
hr107, which were selected directly from high titer MVMi
stocks, as distinct plaques on A9 fibroblast monolayers. In
contrast to host range mutants isolated to date, these mutants
each have only a single point mutation in the VP2 gene, at
D399, in addition to a silent guanine-to-adenine mutation in
the upstream, non-structural protein gene region. This
upstream mutation leads to dramatic increases in NS2
accumulation, which appear to promote viral fitness in a
number of ways, most notably allowing the enhanced
production and early release of progeny virions. These
mutants thus highlight the importance of cell type specific
differences in protein expression and virion release mech-
anisms in modulating viral tissue tropism.Table 1
Genotypes of viruses used in this study
Genotype/name MVM nucleotide VP2 aa 399
1967 1970 3989–91
ggD (MVMi) g g gat D
ggA g g gct A
ggG g g ggt G
gaD g a gat D
agD a g gat D
gaA (hr105) g a gct A
agG (hr107) a g ggt G
gaG g a ggt G
agA a g gct AResults
Host range switch mutants hr105 and hr107 each carry two
mutations
Host range variants of MVMi were isolated by direct
plaque selection on A9 monolayers from high titer viral
stocks, and the sequences of their entire coding regions
determined from PCR-amplified products. In both cases,
two mutations were detected. hr105 carried a silent guanine-
to-adenine change at nucleotide 1970 and an adenine-to-
cytosine change at nucleotide 3990, which introduced a
D399A mutation in the capsid VP2 polypeptide. The second
mutant, hr107, had a silent guanine-to-adenine change at
nucleotide 1967, coupled with an adenine-to-guanine
change at nucleotide 3990, resulting in a D399G mutation
in the capsid gene. The positions of these mutations are
indicated on the MVM genome in Fig. 1. VP2 amino acid
399 is positioned on the surface of the viral capsid,
specifically on the rim of the 2-fold dimple depression
immediately adjacent to the base of the 3-fold spike, and has
been identified previously as one of co-ordinated pairs of
mutants that are capable of mediating the MVMi-to-MVMp
host range switch (Agbandje-McKenna et al., 1998). The
silent gYa mutations at nucleotides 1967 and 1970 in theMVMi sequence are shown in Fig. 1, relative to the MVM
transcription map. These mutations do not affect the coding
sequences of NS1 or NS2, as shown, but are located just
upstream of the 3V splice junction of the major intron that
differentiates R1 transcripts, encoding NS1, from R2 tran-
scripts, encoding the NS2 isoforms. Specifically, R2 tran-
scripts are derived from R1 transcripts prior to nuclear
export by removal of this second intron, so that the relative
expression of the two NS proteins is modulated, at least in
part, by the efficiency of this splice.
Introduction of the hr105 or hr107 mutations into an
infectious clone of MVMi confirmed that in both cases these
two changes were necessary and sufficient to confer
fibrotropism, but the two sets of changes appeared so
similar that we suspected they might define two inter-
changeable classes of mutation. To explore this possibility,
and to probe potential mechanisms that could allow the
silent upstream changes to modulate host range, we
introduced each change by itself or in pairwise combina-
tions into the infectious plasmid clone of MVMi, creating
the range of genotypes depicted in Table 1.
A non-coding mutation at nucleotide 1967 or 1970
complements either VP2 change at D399 to promote
productive infection in fibroblasts
Virus stocks of each genotype were generated by
transfection into the transformed human cell line 324K,
which supports the growth of both lymphotropic and
fibrotropic MVM strains. Virions were purified by centri-
fugation through iodixanol gradients, nuclease digested, and
genomes quantitated by Southern transfer following dena-
turing gel electrophoresis. Each virus was then tested for its
ability to grow productively in A9 fibroblasts, EL4
lymphocytes, and the cell line iD5, a somatic hybrid
between A9 and EL4. For this, we used an immunofluor-
escence-based expansion assay in which we measured the
viruses’ ability to spread through a culture during the 72 h
following low multiplicity infection, by comparing the
proportion of cells expressing the viral NS1 polypeptide
when cultured in the presence, versus the absence, of
neutralizing antibody.
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effectively in cultures of iD5 cells, although the original
MVMi genotype (ggD) appeared somewhat less fit than the
other viruses, suggesting that these hybrid cells might show
a slight bias towards fibrotropic MVM strains. In contrast,
MVMi- and MVMi-based viruses carrying any single
mutation expanded very poorly, if at all, through A9
fibroblast cultures (Fig. 2B). Specifically, MVMi and
mutants that carried only one of the non-coding changes,
at nucleotides 1967 (gaD) or 1970 (agD), were completely
unable to expand in these cells, while those carrying eitherFig. 2. Multiple cycle viral expansion reveals productive or restrictive
interactions. Viral expansion was measured, at 72 h post-infection, as the
percent NS1 positive staining cells in adherent cultures of iD5 hybrid cells
(panel A) and A9 fibroblasts (panel B), and in suspension microcultures of
EL4 lymphoma cells (panel C). Assays were performed as described in the
Materials and methods section. Cells infected at low multiplicity were
cultured in the absence of antiviral antibody (filled bars) or in its presence
(open bars).of the capsid coding changes at nucleotide 399 alone (ggA
or ggG), expanded poorly. However, all viruses carrying
both a non-coding change and a coding change, in any
combination, grew efficiently, so that mutating VP2 residue
D399 to either alanine or glycine, while itself insufficient to
confer the ability to expand through a fibroblast population,
could be complemented with guanine to adenine changes at
either 1967 or 1970. Thus, the two pairs of mutations seen
in hr105 and hr107 are effectively interchangeable, but one
mutation of each type is required to confer a successful
fibrotropic phenotype.
In contrast, all viruses carrying single mutations that
replaced the aspartic acid at VP2 residue 399 were unable to
grow productively in EL4 lymphocytes, whether or not they
carried mutations at positions 1967 or 1970 (Fig. 2C).
Indeed, expansion of ggD, gaD, and agD genotypes
appeared indistinguishable in these cells, so that whatever
the molecular consequences of the silent upstream muta-
tions, they appear to have little, if any, influence on the
viruses’ growth in EL4 lymphocytes in this assay. The
mutation of D399 thus profoundly alters the host range in
the context of the MVMi genome, even though an aspartic
acid residue also occupies this position in the VP2
polypeptide of MVMp.
These assays also showed that viral spread was intrinsi-
cally less efficient in the EL4 cultures than in A9 or iD5
cells. Thus, the initial input multiplicities needed to
demonstrate significant virus propagation over 72 h were
10-fold higher in EL4 cells than in the other two cell lines,
and, for even the fittest viruses, the eventual fraction of
NS1-expressing cells in the culture was substantially lower.
This was somewhat surprising, since the EL4 cells were
grown in suspension culture, whereas the other two lines
were infected as monolayers, in which viral spread might be
expected to be less efficient. This difference in culture
system means that it is not possible, from the expansion data
alone, to tell whether the poor rate of spread was an EL4
cell-intrinsic characteristic or simply resulted from an
unsuspected inefficiency of virus transmission between
cells in suspension.
The non-coding changes at nucleotides 1967 and 1970 have
a dramatic influence on the relative accumulation of NS1
and NS2 polypeptides
The ability of each genotype to express each of the viral
proteins was determined by Western analysis 24 h post-
infection. As seen in Fig. 3A, when infected cell extracts
from the hybrid line, iD5, were probed with an antibody that
detected the common amino-terminal peptide shared by
NS1 and NS2, each virus was seen to have generated similar
levels of NS1, but NS2 accumulation varied dramatically
depending upon the nucleotide present at positions 1967 or
1970. While NS1 concentrations appear fairly constant in
these genome-matched infections, the NS2 concentrations
appear to fluctuate, and, for the sake of clarity, we will
Fig. 3. Expression of viral non-structural proteins. Viral non-structural
protein expression was measured, at 24 h post-infection of adherent cultures
of iD5 hybrid cells (panel A), A9 fibroblasts (panel B), and of suspension
microcultures of EL4 lymphoma cells (panel C). Infections and Western
blots were performed as described in the Materials and methods section,
using an antibody specific for the common N-terminal of NS1 and NS2.
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proteins as an NS2:NS1 ratio. Thus, an increase in this
ratio indicates an increase in NS2 accumulation, and
generally also indicates an increase in the total concentration
of NS proteins, as measured 24 h post-infection. Fig. 3A
shows that, in the absence of either of the upstream
mutations, the NS2:NS1 ratio found in infected iD5 cells
was approximately 1:2, but in the presence of either silent
change, the relative accumulation of NS2 was enhanced ¨6-
fold, so that NS2 molecules outnumbered NS1 by approx-
imately 3-fold (i.e., the NS2:NS1 ratio was ¨3:1). Since
both the single and double mutants spread effectively
through these cultures (Fig. 2A), it appears that NS2:NS1
ratios of either 1:2 or 3:1 are compatible with productive
infection in these cells.
In contrast, all three viruses carrying the parental D399
residue initiated infection of A9 cells extremely poorly,
expressing only trace levels of the non-structural proteins, as
seen in Fig. 3B. However, all viruses carrying either the
D399A or D399G capsid mutation expressed approximately
similar levels of NS1 24 h post-infection, even though thesingle mutants were subsequently unable to expand through
these cultures (Fig. 2B). Strikingly, NS2 accumulation in A9
cultures was severely restricted, and NS2:NS1 ratios were
much lower than those seen in iD5 cells. While, the silent
upstream gYa mutations again had the effect of increasing
these ratios, in A9 cells, they increased them from only
¨1:5 for viruses with gg genotype to approximately 1:2 for
viruses with the ga or ag genotypes. Thus, absolute NS
protein expression levels and an NS2:NS1 ratio of 1:2, seen
for viruses with gg genotypes in iD5 cells, were only
achieved in A9 cells by the ga or ag mutants. This indicates
that NS2 expression and/or accumulation are exceptionally
limited in A9 cells, so that in the single mutants NS2-
mediated functions might well be compromised. Under
these circumstances, the enhanced NS2 expression in the
double mutant that results from the silent upstream hr105
and hr107 adenine substitutions, may simply restore a
productive NS2:NS1 balance.
Finally, as seen in Fig. 3C, in EL4 lymphocytes, the host
range specificity was dramatically reversed, so that efficient
initiation was only seen for the three viruses that carried the
parental D399 residue, and relatively little non-structural
protein accumulation was seen for mutants with the alanine
or glycine coding changes. However, for all viruses carrying
D399, NS1 levels achieved in the first round of EL4
infections were very similar to those seen in productive A9
infections, while NS2 levels were exceptionally high
(NS2:NS1 = >5:1), whether or not the viruses carried either
the 1967 or 1970 gYa change. Thus, the NS2:NS1 ratios in
EL4 cells were effectively inverted relative to those seen in
A9 cells, and the overall NS protein accumulation was
markedly elevated. In infections with the gaD and agD
single mutants, there was more evidence of NS-protein
degradation and/or modification than in the wild type
MVMi (ggD) infection (Fig. 3C), so that one or other NS
protein may be preferentially degraded and/or conjugated,
and therefore under-represented as unit-length molecules, in
these samples. Nevertheless, the NS2:NS1 ratio changes
characteristic of iD5 or A9 infections with viruses carrying
the silent upstream mutations were more apparent in the
restrictive infections of EL4 cells, with the double mutants
again showing substantially higher NS2 accumulation than
their single mutant (ggA or ggG) counterparts. These
analyses therefore demonstrate that efficient initiation of
infection is determined by the specificity of the capsid
amino acid at position 399, but that the ensuing accumu-
lation of NS2, relative to NS1 molecules, is very different in
lymphocytes and fibroblasts, and may be limiting in A9
cells.
Importantly, the gels used here to compare protein
expression in A9 fibroblasts and EL4 lymphocytes were
prepared, transferred, and probed simultaneously, so that the
levels of protein accumulation seen in the two cell types
directly reflect their equivalent input multiplicities (compare
Figs. 3B and C), rather than any sampling anomalies.
However, as seen for the iD5 cells in these single round
Fig. 4. Expression of viral structural proteins. Viral structural protein
expression was measured, at 24 h post-infection of adherent cultures of iD5
hybrid cells (panel A), A9 fibroblasts (panel B), and of suspension
microcultures of EL4 lymphoma cells (panel C). Infections and Western
blots were performed as described in the Materials and methods section,
using an antibody specific for the common C-terminal region of VP1 and
VP2.
Fig. 5. Replication and accumulation of viral DNA. Viral DNA was
extracted, at 24 h post-infection of adherent cultures of iD5 hybrid cells
(panel A), A9 fibroblasts (panel B), and of suspension microcultures of EL4
lymphoma cells (panel C). Infections and Southern blots were performed as
described in the Materials and methods section, using a full length viral
genomic probe.
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rise to much lower cumulative NS1 and NS2 concentrations
for viruses with the gg genotype than for those carrying ag
or ga sequences at the upstream loci. This suggests that by
24 h post-infections, overall NS protein accumulation is
substantially more efficient in situations where NS2 levels
are elevated.
These blots were then stripped and re-probed for capsid
protein expression, as shown in Figs. 4A–C. As expected,
all genomes induced efficient accumulation of capsid
polypeptides in iD5 cells (Fig. 4A). However, the upregu-
lation of NS expression seen in the 1967/1970 gYa mutants
was mirrored by a ¨2-fold increase in the accumulation of
VP1 and VP2, in protein degradation, and, presumably, in
protein conjugation, since higher molecular weight forms of
the VP proteins were apparent in all infections with viruses
carrying either upstream mutation.
The silent upstream mutations had little effect on capsid
protein accumulation in A9 and EL4 cells, which, as would
be expected, was predominantly determined by the residueat position 399 in VP2 (Figs. 4B and C). Thus, only viruses
carrying the D399A and D399G mutations achieved high-
level capsid expression in A9 cells and, reciprocally, failed
to achieve efficient capsid expression in EL4 lymphocytes.
Finally, the limited viral expansion of lymphotropic
viruses seen previously in EL4 cells (Fig. 2C) appears to
reflect a problem in viral spread rather than in initiation
efficiency, since viral protein expression in single-round,
high input multiplicity infections, as assessed in these
Western blots, was at least as efficient in EL4 cells as in the
other two cell lines.
Accumulation of replicative-form DNA depends on VP2
residue 399, but progeny genome accumulation is
influenced by the 1967 or 1970 gYa changes
For all of these studies, cells were cultured in the
presence of the receptor destroying enzyme neuraminidase
following removal of the viral inocula, in order to prevent
newly released progeny virus from binding back to the cells.
This allows us to distinguish between progeny single-strand
accumulation in the cells and subsequent release of these
genomes, as virions, into the culture medium. As seen in
Fig. 5A, in iD5 hybrid cells, monomer and dimer
replicative-forms (RF) accumulated to similar levels for all
viruses. However, progeny single-strand accumulation in
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its release into the culture supernatant (in lanes marked S)
were both much more efficient in viruses expressing higher
levels of NS2. Although during the 24 h time course of this
study at least some progeny production and release were
seen for two of the three viruses with low NS2 accumulation
levels (ggD and ggA), it should be noted that released virus
can often be under-represented in such dilute samples, most
likely because it tends to stick to the culture dish. Since the
gg viruses did spread productively through equivalent iD5
cultures over the course of 72 h, as seen in Fig. 2A, we
presume that these observations mean that genome produc-
tion and release were simply diminished and retarded in
viruses with gg genotypes, but that it did occur. In contrast,
viruses that carried the 1967 or 1970 non-coding gYa
mutations, and hence expressed elevated levels of NS2,
generated substantially more single-stranded progeny virus,
and this was almost quantitatively released from the cells
prior to cell death, as evidenced by the relative lack of
replicative-form DNA in the culture supernatants.
In A9 fibroblasts (Fig. 5B) and EL4 lymphocytes (Fig.
5C), high level monomer and dimer RF accumulation once
again simply reflected the presence or absence of an aspartic
acid residue at VP2 position 399. However, despite
substantial RF accumulation in A9 cells, the single mutant
genotypes ggA and ggG, which failed to expand in these
cells in assays shown in Fig. 2B, generated few progeny
single-stranded genomes, and apparently failed to release
detectable amounts of virions into the culture medium. In
contrast, viruses carrying the 1967 or 1970 gYa mutations,
with their relatively elevated NS2 concentrations, generally
showed enhanced single-strand accumulation and release.
This suggests at least two mechanisms whereby the elevated
NS2 levels seen in the double mutants might critically
influence virus spread: firstly, by promoting the production
of progeny virus through mechanisms such as enhanced
capsid assembly (Cotmore et al., 1997); and secondly, by
mediating early progeny release from viable cells (Cotmore
et al., 1997; Eichwald et al., 2002; Miller and Pintel, 2002),
so that subsequent rounds of infection are initiated rapidly.
The low levels of progeny virus detected following infection
of A9 cells with the double mutants, shown in Fig. 5B,
appear to be at odds with the extensive expansion of these
viruses in A9 cells shown in Fig. 2B. Since the analysis in
Fig. 5B represents a single time point, it may well be that the
kinetics of progeny packaging and/or release are slower in
A9 cells for the MVMi-based double mutants than for
MVMp infections, upon which this timepoint was predi-
cated. The MVMp genome differs from that of MVMi at
over 150 additional nucleotides, and many of these may be
adaptive mutations that accelerate the growth of MVMp in
A9 cells.
Finally, in productive infections of EL4 lymphocytes,
progeny single-strand accumulation was extraordinarily
efficient in productive infections, whether or not the
upstream gYa mutations were present, so that progenyvirus accounted for approximately one third of the total
MVM DNA present in these cells. However, we could find
absolutely no evidence that these virions were released from
infected EL4 cell at this stage of the infection. This suggests
that, despite very high levels of NS2 accumulation and very
efficient progeny virus production, the mechanism for the
early release of progeny virus prior to cell lysis seen in the
other host cells, does not operate in EL4 cells, at least by the
time examined. The impaired ability of even the most
efficient viruses to spread through EL4 cell populations,
seen in the expansion assays, therefore likely reflects their
delayed release from successive cohorts of infected cells.Discussion
In this study, we show that a single codon change in the
MVMi VP2 capsid gene that converts the aspartic acid at
residue 399 to either alanine or glycine effectively switches
the virus from a lymphotropic to a fibrotropic phenotype.
However, such mutants are so impaired for expansion in
fibroblasts that they effectively remain restricted. Since they
also become completely defective for growth in their
original lymphocyte host, such mutants would not be
expected to accumulate in laboratory virus stocks grown
in these cells. However, acquisition of a second, silent,
mutation in the non-structural gene region, relieves this
fitness deficit in fibroblasts, allowing virus amplification to
outpace cell division. While several fibrotropic host range
mutants of MVMi have been described previously, these
have invariably acquired two capsid sequence changes that,
like D399, map to a region surrounding or lining the walls
of the depression, also termed the dimple, positioned at the
2-fold axis of the viral icosahedron. Significantly, we have
also observed accumulation of gYa mutations at nucleo-
tides 1967 or 1970 in these MVMi double capsid mutants
during continuous passage in A9 cells (Wang, F., and
Tattersall, P., unpublished observations), supporting the
conclusion that such changes are markedly adaptive for
virus growth in these cells. Nevertheless, the original capsid
double mutants were able to expand through A9 cultures
without the upstream changes, suggesting that the D399
mutations in hr105 and hr107 capsids somehow uniquely
impair virus spread.
What is the function of the upstream, non-coding mutations?
MVM nucleotides 1967 and 1970 are positioned in the
coding region of the large non-structural protein NS1, just
upstream of the second exon of NS2 (see Fig. 1). The R1
class of transcripts that encode NS1 has their small intron
removed by alternative splicing, but if their export from the
nucleus is delayed, a further, major, splice occurs, generat-
ing the R2 transcripts that encode the NS2 isoforms (Pintel,
in press). Significantly, the 3V splice site for the major intron
is located just downstream of the silent mutations, at
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within the putative branch point region for the splice.
Guanine to adenine changes at either of these two positions
might improve the efficiency with which the major intron is
removed by providing additional branch points. However,
neither of the new adenine residues would conform well to
the (C/T)T(G/A)A(C/T) consensus for the context of known
branch points (Senapathy et al., 1990), suggesting rather
that the change may optimize an accessory sequence for the
function of the branch point or of the 3V splice site. However
it may occur, such enhanced splicing efficiency of R1 to R2
would be predicted to promote synthesis of NS2 at the
expense of NS1, as is observed as a consequence of either
upstream gYa change in most of the infections we studied.
Significantly, the major splice of MVMp, which naturally
has an adenine at nucleotide 1970, has recently been shown
directly to function more efficiently in mouse fibroblasts
than does its MVMi counterpart. In EL4 cells, however,
MVMi excises its large intron, and expresses NS2, to the
same high level as does MVMp in murine fibroblasts,
indicating that cell type specific differences in splicing
efficiency do exist, although exactly how these operate
remains uncertain (Choi et al., 2004).
Thus, it appears likely that differences in splicing
efficiency are responsible for the modulation in NS2:NS1
ratios seen here in genomes carrying upstream gYa
nucleotide changes. In the present study, viral protein
expression was analyzed 24 h after infection at saturating
input multiplicities (104 genomes per cell), and under these
conditions, genomes that exhibited enhanced NS2 accumu-
lation also showed a cumulative increase in the overall
concentration of all non-structural proteins. This suggests
that elevated NS2 expression, while mechanistically occur-
ring at the expense of NS1 transcripts, subsequently led to
enhanced overall expression and/or stabilization of the NS
gene products during the course of a single round of
infection. This is particularly noteworthy since, during
infection of A9 cells, NS2 polypeptides are known to be
turned over rather rapidly, by a proteasome-mediated but
ubiquitin-independent interaction, whereas the half-life of
NS1 under these conditions is in excess of 6 h (Cotmore and
Tattersall, 1990; Miller and Pintel, 2001). Thus, if all else
remained equal, enhanced NS2 expression would be
expected to correlate with an overall diminution in NS
protein accumulation. However, NS2 isoforms are pleio-
tropic, are absolutely required for early steps in MVM
infection of murine cells, and are expressed at their highest
levels at these early time points (Naeger et al., 1990; Cater
and Pintel, 1992; Brockhaus et al., 1996; Cotmore et al.,
1997), so that the correlation between enhanced overall
accumulation of the P4 gene products and elevated NS2
expression may simply indicate more rapid and efficient
take-over of the host cell by the infecting virus. Remarkably,
even the upstream gYa mutants only achieved NS2:NS1
ratios of 1:2 in A9 fibroblasts, whereas in productive
infections of EL4 cells, the ratios were invariably >5:1, andoverall NS accumulation appeared ¨10-fold higher, perhaps
suggesting that NS2 expression for all of these mutant
viruses may remain sub-optimal in A9 cells.
How does enhanced NS2 expression affect progeny virus
production?
While a role for NS2 in species-specific host range is
well documented in the literature, here we describe a
hitherto unsuspected, dose-dependent role for NS2 in tissue-
specific tropism within the same host species, involving late
viral processes rather than initiation of infection, which is
controlled by the capsid. Elevated NS2 levels correlated
with the enhanced accumulation of progeny single-strand
DNA and, in A9 and hybrid cells, with the early release of
packaged genomes into the culture supernatant. NS2 is
known to influence many aspects of the viral life cycle, from
the onset of duplex DNA replication to the assembly of
empty viral capsids and the release of full virions from
certain cell types prior to cell death (Naeger et al., 1990,
1993; Brockhaus et al., 1996; Cotmore et al., 1997;
Bodendorf et al., 1999; Ohshima et al., 1999; Miller and
Pintel, 2002; Eichwald et al., 2002; Lopez-Bueno et al.,
2004). Thus, the elevated NS2 levels seen here likely
influence progeny virus production in multiple ways.
Whether or not NS2 is directly involved in the
mechanism, as yet poorly-understood, that diverts DNA
replication from duplex amplification to progeny single-
strand displacement synthesis and encapsidation, remains
uncertain. Such a link appears unlikely since, when
expressed in trans from the viral P38 promoter, NS2
appeared able to complement every defect seen in NS2-
null virus infections of A9 cells, except for the ability to
generate progeny single-strands (Cotmore, S.F., Gottlieb,
R., D’Abramo, A., and Tattersall, P., unpublished observa-
tions). Remarkably, despite the accumulation of extremely
high NS2 levels and exceptionally efficient progeny virus
production, EL4 cells appeared unable to export or release
virus by 24 h p.i., and perhaps prior to cell death. This may
explain why virus spread in EL4 cells, as measured over a
72 h period in the expansion assays (Fig. 2), was so much
less efficient than its dissemination through A9 and iD5
cultures.
Since the nucleus is the site of MVM capsid assembly,
DNA replication, and packaging, it follows that release of
infectious virions from the cell prior to general lysis will
require prior export from the nucleus, for which two
mechanisms are currently recognized. The predominant
mechanism that operates in A9 cells is sensitive to
leptomycin B, indicating that it is dependent upon the
nuclear export factor Crm1, with which NS2 interacts
(Bodendorf et al., 1999; Ohshima et al., 1999). Indeed,
mutations within the Crm1 binding site of NS2 that disrupt
this interaction lead to retention of virions in the nucleus,
although extensive efforts have failed to demonstrate any
interaction between assembled capsids or virions with NS2
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Lopez-Bueno et al., 2004). An alternative, leptomycin B-
resistant mechanism predominates in SV40-transformed
human 324K cells, where nuclear export of virions is
dependent upon the exposure, at the surface of packaged
virions, of specific phosphorylated serine residues at the
extreme N-terminus of VP2 (Maroto et al., 2000, 2004).
Despite being independent of the Crm1 nuclear export
pathway in these cells, some essential step in the egress of
packaged virions requires NS2, as 324K cells infected with
NS2-null mutants accumulate abundant packaged virus, but
fail to export it into the medium (Cotmore et al., 1997).
Further evidence for the intimate involvement of NS2 in
virion egress is provided by the recent characterization of
MVMi mutants that escape passive polyclonal antibody
therapy in an immunodeficient mouse disease model
(Lopez-Bueno et al., 2004). These mutants display a variety
of amino acid substitutions within NS2 that increase the
affinity of its interaction with Crm1, and simultaneously
accelerate export of virions from the infected cell, a process
which appears to underlie their escape from post-entry
antibody neutralization. It would be interesting to test
whether such gain-of-function mutations in NS2 could
substitute for the upregulatory gYa mutations at nucleo-
tides 1967 or 1970 in enhancing the spread, in A9 cells, of
the VP2 D399A or G mutants explored in this study. Despite
this variety of pathways that operate for exporting virions
out of the infected cell, none appear to operate in EL4 cells.
An apparently similar host range switch in which an
upstream guanine-to-adenine change was required to
support specific capsid mutations was recently reported
for MVMp-based viruses cultured in Fischer rat fibro-
blasts (Etingov et al., 2004). The upstream mutation was
again a non-coding gYa change, in this case at
nucleotide 1955, four codons upstream of the hr107
change, and rendered the resulting viruses highly patho-
genic in rat embryos. Whether or not this mutation also
boosts NS2 levels, and/or increases progeny virus
formation or its release, remains to be explored. However,
in this case, the starting virus, MVMp, already carries an
adenine at nucleotide 1970, and so would be expected to
exhibit relatively elevated NS2 levels, at least in murine
cell lines. While this may suggest that the gYa mutation
at nucleotide 1955 promotes growth in rat fibroblasts via
an entirely different mechanism, it is also possible that
NS2 expression in these cells remains suboptimal even
for MVMp, so that any mechanism that enhances its
production might impact positively on infection.
Productive versus restrictive infection
An inverse, but comparable, host range effect was
described previously for viral chimeras constructed between
MVMp and MVMi genomes that were being tested for their
ability to replicate in EL4 lymphocytes (Colomar et al.,
1998). In this case, a segment of the MVMi genomebetween nucleotides 1084 and 2070 was required to
complement a fragment from the MVMi capsid (nucleotides
3523 to 4339) in order to confer lymphotropism on an
otherwise MVMp-based virus. The presence of the upstream
MVMi sequence was specifically shown to restrict NS2
mRNA accumulation, and a change in splicing efficiency
was postulated as the probable underlying cause. Thus, in
this case, a reduction in NS2 expression appeared to
promote growth of an MVM recombinant in EL4 cells,
although in the present study we failed to detect any such
influence of upstream sequences on the growth of D399-
bearing viruses in the same cell line. As discussed earlier for
the growth of D399 versus double MVMi capsid mutants in
A9 cells, this indicates that concurrent upstream changes
influencing NS2 accumulation may only be required to
consolidate VP2 changes in particular subsets of host range
mutants.
Thus, the major conundrum remaining is why these
particular mutants require elevated NS2 levels in order to
replicate productively in fibroblasts, whereas the double
capsid mutants such as LB1 appear to benefit from
acquiring such changes, but do not absolutely require them
for productive growth. Possibly, cellular changes induced by
high NS2 levels might alter the structure of the particle in a
specific way that complements the 399 mutation, perhaps by
modulating the assembly process or by promoting specific
post-translational modifications. However, the D399 to A or
G single mutants described here were clearly able to enter
A9 cells, become uncoated, express their genes, and
replicate their DNA, which takes them far beyond any of
the specific interactions previously postulated as candidate
host range restriction points (Ball-Goodrich and Tattersall,
1992; Colomar et al., 1998; Spalholz and Tattersall, 1983).
Thus, the simplest explanation for the D399 mutants’
continued restriction would be that their capsids are
potentially fibrotropic, but are in some way structurally
sub-optimal, perhaps showing assembly defects that lead to
impaired binding of cell receptors or imperfect cell-entry
related structural transitions. In such a suboptimal capsid
background, the additional growth impediments, such as
lower NS gene product accumulation, depressed progeny
virus production, or inhibition of early progeny release, to
which viruses replicating in murine cells with a low NS2
environment appear to be subject, might prove overwhelm-
ing, and shift the interaction from a potentially productive to
a restrictive infection.Materials and methods
Cells and viruses
324K cells are Simian Virus 40-transformed human
newborn kidney cells that support growth of both fibrotropic
and lymphotropic MVM strains. The A9ouabr11 fibroblasts
used here (called A9) are ouabain-resistant derivatives of the
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T cell lymphoma, and iD5 is a subclone of the somatic cell
hybrid line Hyb 1/11, which was formed by fusion of A9
with EL4 cells as described previously (Tattersall and
Bratton, 1983), and is a productive murine host for both
MVMi and MVMp.
Mutants hr105 and hr107 were isolated from single
plaques obtained on A9 fibroblasts infected with a high titer,
plasmid-derived stock of MVMi, and were routinely
amplified in these cells. The entire coding region of each
virus was amplified in sequential steps by PCR from virion
DNA and the products sequenced by standard techniques.
Site-directed mutant viruses were created by substitution of
PCR amplified mutant sequences into an infectious plasmid
clone of MVMi, and transfection into 324K cells using
Lipofectamine (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions, followed by culture until
complete cytopathic effect was observed. Virus was released
from infected cells by three cycles of freezing and thawing
in 50 mM Tris–HCl, 0.5 mM EDTA, pH 8.7 (TE8.7). These
stocks were further expanded by one passage in 324K cells
initiated at low multiplicity, and virions purified by
centrifugation through an iodixanol (Optiprep, Axis-Shield,
Oslo, Norway) step gradient (55% and 45% iodixanol in
phosphate buffered saline, 1 mM MgCl2, 2.5 mM KCl, pH
7.2, and 35% and 15% in TE8.7) at 35,000 rpm for 18 h at
18 -C in a Beckman SW41 rotor. Gradients were collected
from the bottom of the tube and viral particles detected by
their ability to hemagglutinate guinea pig erythrocytes.
Genome copy number was determined by digesting
gradient fractions with micrococcal nuclease, followed by
electrophoresis through denaturing agarose gels, Southern
transfer, hybridization with 32P-labeled random primed
oligonucleotide probes generated using a genome-length
MVM template, and quantitation by PhosphoImager anal-
ysis. Genome concentrations were calculated, using a value
of 4  108 genomes per nanogram of DNA, by comparison
with plasmid standards run in parallel on the same gel.
Expansion assays
The ability of each genotype to expand through A9 and
iD5 cell populations was determined by infecting cells,
seeded at 20% confluence on microscope ‘‘spot’’ slides, with
virus at a multiplicity of 30 genomes per cell. Virus inocula
were removed from duplicate spots after 3 h and the cell
monolayers cultured for a further 15 h. Culture supernatants
were then replaced with normal medium or with medium
containing 1% neutralizing rabbit anti-MVM serum. Fol-
lowing incubation for a further 54 h (i.e., 72 h post-
infection), cells were fixed, stained for indirect immuno-
fluorescence using the CE-10 NS1 specific monoclonal
antibody (Yeung et al., 1991), detected by goat anti-mouse
IgG conjugated with Texas Red, and counterstained with 4-
6-diamidino-2-phenylindole (DAPI). For each data point,
5–10 random fields were photographed, and between 200and 1000 cells were counted, depending upon the fraction
positive for NS1. Expansion through EL4 cultures was
determined in suspension microculture. For this, EL4 cells
were infected with 300 genomes per cell in duplicate wells
of a 24 well plate for 18 h. Neutralizing rabbit anti-MVM
serum (1%) was then added to one set of wells, and at 48 h
post-infection, all cells were split 1:4 into separate wells. At
72 h post-infection, 200,000 cells were centrifuged on to
slides, fixed, stained, and counted as described above.
Protein expression and Western transfers
A9 or iD5 cells were seeded as monolayer cultures at
25% confluence and infected with 1  104 viral genomes
per cell. Plates were rocked every 30 min for 4 h, when viral
inocula were removed and the cultures incubated with fresh
medium containing 0.04 units per ml of neuraminidase
(Clostridium perfrigens, Type V, Sigma, St. Louis, MO), to
prevent re-infection, for another 20 h. Cells were harvested
by scraping into the medium, collected by centrifugation in
aliquots, resuspended in a cocktail of protease inhibitors in
phosphate buffered saline and frozen. EL4 cells were
infected in suspension microculture at the same multiplicity
as the A9 and iD5 cells. At 4 h post-infection, EL4 cells
were collected and spun down to remove virus inocula, re-
plated, and processed as for the monolayer cultures.
To assess protein expression, cell pellets were fractio-
nated by electrophoresis through discontinuous 11% poly-
acrylamide gels in the presence of sodium dodecyl-sulfate
(SDS-PAGE), transferred electrophoretically to Immun-Blot
PVDF Membrane (Bio-Rad Laboratories, Hercules, CA)
using a Bio-Rad mini trans-blot transfer cell, and probed
with rabbit antisera as indicated. Blots were developed using
HRP-conjugated goat anti-rabbit IgG, and bands detected by
ECL according to standard procedures.
DNA replication and Southern transfers
Cells were seeded and infected as for protein expression,
described above, including culture in neuraminidase con-
tinuously from the point, 4 h post-infection, when virus
inocula were removed. One plate of cells infected with each
virus was harvested at 6 h post-infection, to serve as input
controls, and test plates were harvested 24 h post-infection.
During harvest, cells were scraped into the medium, pelleted
out by centrifugation, and both cells and medium stored
frozen.
Cell pellets were resuspended in 150 mM NaCl, 20 mM
Tris–HCl, 10 mM EDTA pH 7.5, and total DNA was
extracted from both pellets and culture supernatants by
incubation with proteinase K at 200 Ag/ml in the presence of
1% SDS for 30 min at 37 -C, followed by 4 h at 60 -C.
Samples were extracted twice with a phenol, chloroform,
and isoamyl alcohol mixture, twice with ethyl ether and then
ethanol precipitated in the presence of 100 mM sodium
acetate pH 7.0 and carrier tRNA. Precipitates were collected
A.M. D’Abramo Jr. et al. / Virology 340 (2005) 143–154 153by centrifugation, washed with 70% ethanol, and briefly
dried, before being digested with RNase A, re-extracted
twice with the phenol mixture, and ethanol precipitated.
Samples were analyzed by electrophoresis through native
agarose gels, and transferred to Zeta probe membranes (Bio-
Rad) according to standard procedures. Blots were hybri-
dized with 32P-labeled random primed oligonucleotide
probes generated using the full MVM genome as template.Acknowledgments
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